overlay landing page

We found 381 Investors in New Jersey on Angels Partners

main investor picture
Delaware Crossing Investor Group
Investing in Robotics • Life Science
 Philadelphia, U.S.A.
Investor Picture
Previous Investments
  • Novira Therapeutics: $25000000 (Early stage VC)
  • QR Pharma: $5700000 (Early stage VC)
  • Medcura: $3020000 (Early stage VC)
  • Life.io: $1500000 (Seed Round)
  • Stabiliz Orthopaedics: $1280000 (Seed Round)
  • Compliance Assurance: $1250000 (Later stage VC)
  • NanoPack: $1100000 (Later stage VC)
  • Hulafrog: $500000 (Seed Round)
  • Snowvation: $500000 (Seed Round)

Delaware Crossing Investor Group

Philadelphia, U.S.A.

Contact this investors  
Investing In

Robotics • Life Science

Description

Delaware Crossing Investor Group is a network of former and current executives and entrepreneurs who provide counsel and capital to early-stage and growing companies. The firm is a membership organization of investors who manage the investment process and serve as the board of directors of portfolio companies. It is based in Warrington, Pennsylvania and was founded in 2005.

main investor picture
Edison Partners
Investing in Software (Web Marketplace Saas..) &b...
 Princeton New Jersey, U.S.A.
  • main investor picture
    Christopher Clarke
    Partner
  • main investor picture
    Lenard Marcus
    Partner
  • main investor picture
    David Nevas
    Partner
  • main investor picture
    Daniel Herscovici
    Partner
  • main investor picture
    Del Giannotti
    Associate
  • main investor picture
    Gary Golding
    General Partner
  • main investor picture
    Gregg Michaelson
    Partner
  • main investor picture
    Jay Ganesan
    Analyst
  • main investor picture
    Joe Allegra
    General Partner
  • main investor picture
    Kelly Ford Buckley
    General Partner
  • main investor picture
    Michael Kopelman
    General Partner
  • main investor picture
    Robert Dickey
    Senior Associate
  • main investor picture
    Tom Vander Schaaff
    General Partner
  • main investor picture
    Chris Sugden
    Managing Partner
  • main investor picture
    Jonathan Reynolds
    Senior Associate
  • main investor picture
    Joseph Giquinto
    Vice President, Finance
  • main investor picture
    Ryan Ziegler
    General Partner
  • main investor picture
    Tom Schaaff
    Partner
  • main investor picture
    Christopher Clark
    Partner
  • main investor picture
    Joseph Allegra
    Partner
  • main investor picture
    Jay Naik
    Partner
Investor Picture
Previous Investments
  • LookBookHQ Inc.: $13000000 (Later stage VC)
  • tracx: $12500000 (Later stage VC)
  • LawnStarter: $10500000 (Later stage VC)
  • Zagster: $10000000 (Later stage VC)
  • GAN Integrity Inc: $9000000 (Early stage VC)
  • Solovis: $8000000 (Early stage VC)
  • Signet Accel: $8000000 (Early stage VC)
  • Loci.io: $350000 (Early stage VC)
  • Emplify:
  • SPHERE Technology Solutions: $31000000 (Series B)
  • Get Spiffy: $30000000 (Series C)
  • Get Spiffy: $10000000 (Series B)
  • Field Effect Software: $35000000 (Series Unknown)
  • Field Effect Software: $30000000 (Series A)
  • SPHERE: $31000000 (Series B)
  • Capital Rx: $110000000 (Series C)
  • Capital Rx: $50000000 (Series B)
  • Capital Rx: $12000000 (Series A)
  • NS8: $120000000 (Series A)
  • NS8: $26000000 (Seed)
  • VirtualHealth: $14000000 (Series B)
  • VirtualHealth: $7000000 (Series B)
  • VirtualHealth: $7000000 (Series A)
  • VirtualHealth: $3000000 (Seed)
  • eSentire: $47000000 (Private Equity)
  • eSentire: $20000000 (Series Unknown)
  • eSentire: $13000000 (Series C)
  • eSentire: $7000000 (Series B)
  • Blue Medora: $10000000 (Series B)
  • observIQ: $10000000 (Series B)
  • Bricata: $8000000 (Series A)
  • Lincor Solutions: $9500000 (Venture Round)
  • Lincor Solutions: $10000000 (Series Unknown)
  • Kemp: $16000000 (Series Unknown)
  • KEMP Technologies: $16000000 (Venture Round)

Edison Partners

Princeton New Jersey, U.S.A.

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • Other • IT (& TMT) • Education • Businesses Solutions • FinTech (& Financials services) • Retail (& E-Commerce) • IoT (& Wearables) • HealthTech (& Fitness) • Web Security (& Privacy) • Cloud Services (& Infrastructure) • Future Of Work • Human Resources • Logistics (& Distribution) • Investment Management • Woman Focused

Description

Most Interested In

Enterprise Software, Healthcare IT, and FinTech

main investor picture
    Strange Brew Ventures, LLC
    Investing in Software (Web Marketplace Saas..) &b...
     Shrewsbury New Jersey..., U.S.A.
    Investor Picture
    Previous Investments
    • Sanctuary AI: (Seed)
    • Lightmatter: $80000000 (Series B)
    • FRNGE Inc.: $4000000 (Seed)
    • Permanent Data Solutions Inc.: (Seed)

    Strange Brew Ventures, LLC

    Shrewsbury New Jersey - Atlanta Georgia - Houston Texas - Washington D.C - Usa - Trenton New Jersey - Seattle Washington - San Francisco - Richmond - Los Angeles, U.S.A.

    Contact this investors  
    Investing In

    Software (Web Marketplace Saas..) • Businesses Solutions • FinTech (& Financials services) • Retail (& E-Commerce) • A.I. (& Big Data) • Blockchain (& Cryptos) • Cloud Services (& Infrastructure) • GovTech • Robotics • Aerospace (& Defense) • Woman Focused

    Description

    Most Interested In

    Strange Brew makes direct investments or takes equity as payment for PR. We are a leading PR firm across AI, space/rockets, enterprise software, and more. Most interested in AI/ML seed stage companies, work-from-home technologies, space, automation, enterprise software.

    Not Interested In

    Yet-to-launch blockchain projects (unless heavily backed by VCs), health-tech, IoT.

    main investor picture
      Foundation Venture Capital Group
      Investing in Software (Web Marketplace Saas..) &b...
       ,
      • main investor picture
        Michael Wiley
        Vice President
      • main investor picture
        Aggie Worthington
        Vice President Finance
      • main investor picture
        Alexander Li
        Venture Associate
      • main investor picture
        Sara Soler
        Venture Associate
      • main investor picture
        James Golubieski
        Partner
      Investor Picture
      Previous Investments
      • KayoThera: $750000 (Seed Round)
      • Visikol Inc.: $500000 (Seed Round)
      • NovoPedics: $500000 (Later stage VC)
      • MentiNova: $500000 (Later stage VC)
      • GeneAssess: $500000 (Later stage VC)
      • Affineti Biologics: $500000 (Later stage VC)
      • Snowdon: $500000 (Later stage VC)
      • OculoMotor Technologies: $500000 (Seed Round)
      • Actinobac Biomed: $100000 (Seed Round)

      Foundation Venture Capital Group

      ,

      Contact this investors  
      Investing In

      Software (Web Marketplace Saas..) • Businesses Solutions • Hardware (& Manufacturing) • Logistics (& Distribution) • Investment Management • Life Science

      Description

      Foundation Venture Capital Group is a venture capital firm based in Princeton, New Jersey. The firm primarily invests in the healthcare and health-related technology sectors.

      main investor picture
        Saturn Partners
        Investing in Software (Web Marketplace Saas..) &b...
         New York City , Nashv..., U.S.A.
        • main investor picture
          Jeffrey S. McCormick
        • main investor picture
          Edward Lafferty
          Partner and CFO
        • main investor picture
          Anne Bozik
          Senior Associate
        • main investor picture
          Jeffrey McCormick
          Managing Partner
        • main investor picture
          Bill Guttman
          Partner
        Investor Picture
        Previous Investments
        • Knopp Biosciences: $78110000 (Later stage VC)
        • Yieldstreet: (Seed)
        • Yieldstreet: $4000000 (Seed)
        • Trunomi: $3000000 (Seed)
        • Trunomi: $3000000 (Seed)
        • ClassWallet: $2000000 (Seed)
        • ClassWallet: $2000000 (Seed)
        • Overdog: $2000000 (Series Unknown)
        • Overdog: $100000 (Seed)
        • Overdog: $450000 (Seed)
        • Overdog: $830000 (Seed)
        • Nusirt: $6000000 (Series C)
        • Nusirt: $4000000 (Series A)
        • Nusirt: $2000000 (Seed)
        • Nusirt: $600000 (Seed)
        • Splitwise: $1000000 (Seed)
        • CloudTags: $1000000 (Seed)
        • U Grok It: $600000 (Angel)
        • Learner-Centered Collaborative: $33000000 (Series A)
        • Prompt.ly: $2000000 (Seed)
        • Panopto: $2000000 (Debt Financing)
        • Panopto: $4000000 (Series Unknown)
        • Panopto: $2000000 (Series Unknown)
        • August Home: $2000000 (Seed)
        • 15Five: $1000000 (Seed)
        • RedZone Robotics: $2000000 (Series Unknown)
        • ClariFI: $4000000 (Series Unknown)

        Saturn Partners

        New York City - Nashville Tennessee - Pittsburgh Pennsylvania - Boston Massachusetts - Philadelphia Pennsylvania - Seattle Washington - Wayne New Jersey, U.S.A.

        Contact this investors  
        Investing In

        Software (Web Marketplace Saas..) • IT (& TMT) • Media • Education • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • A.I. (& Big Data) • Gaming (& eSports) • Analytics • Medical Devices (& Hospital Services) • Messaging • Life Science • Online Social

        Description

        Saturn Partners is a venture capital firm based in Boston, Massachusetts. The firm was founded in 1994 and invests in the information technology, electronic commerce and financial technology, as well as select healthcare and advanced material applications.

        main investor picture
        Domain Associates
        Investing in Software (Web Marketplace Saas..) &b...
         New York , Princeton ..., U.S.A.
        • main investor picture
          Nicole Vitullo
          Partner
        • main investor picture
          Brian Dovey
          Partner
        • main investor picture
          Eckard Weber
          Partner
        • main investor picture
          Jesse Treu
          Partner
        • main investor picture
          Brian Halak
          Partner
        • main investor picture
          Adair Newhall
          Principal
        • main investor picture
          Kim P. Kamdar
          Partner
        • main investor picture
          Debra Liebert
          Investor
        • main investor picture
          Dennis Podlesak
          Investor
        • main investor picture
          James Blair
          Partner
        Investor Picture
        Previous Investments
        • Iterum Therapeutics: $65000000 (Series B)
        • Sebacia: $20000000 (Series D)
        • Fractyl Laboratories: $44000000 (Later stage VC)
        • Adynxx: $16000000 (Later stage VC)
        • Antios Therapeutics: $75000000 (Series B)
        • Antios Therapeutics: $96000000 (Series B)
        • Antios Therapeutics: $25000000 (Series A)
        • VentiRx Pharmaceuticals: $51000000 (Series B)
        • VentiRx Pharmaceuticals: $51000000 (Series B)
        • VentiRx Pharmaceuticals: $25000000 (Series A)
        • VentiRx Pharmaceuticals: $27000000 (Series A)
        • VentiRx Pharmaceuticals: $27000000 (Series A)
        • Esperion: $33000000 (Series Unknown)
        • Esperion: $23000000 (Series A)
        • Marinus Pharmaceuticals: $21000000 (Series C)
        • Marinus Pharmaceuticals: $20000000 (Series B)
        • Marinus Pharmaceuticals: $29000000 (Series A)
        • Celator Pharmaceuticals: $20000000 (Series D)
        • Celator Pharmaceuticals: $23000000 (Series C)
        • Celator Pharmaceuticals: $10000000 (Series C)
        • Celator Pharmaceuticals: $20000000 (Series B)
        • Achillion Pharmaceuticals: $50000000 (Post Ipo Equity)
        • Achillion Pharmaceuticals: $50000000 (Post-IPO Equity)
        • Xagenic: $12000000 (Series B)
        • Xagenic: $26000000 (Series B)
        • CoLucid Pharmaceuticals: $37000000 (Series C)
        • CoLucid Pharmaceuticals: $8000000 (Series Unknown)
        • CoLucid Pharmaceuticals: $25000000 (Series B)
        • CoLucid Pharmaceuticals: $17000000 (Series A)
        • Veracyte: $28000000 (Series C)
        • Veracyte: $15000000 (Series Unknown)
        • Veracyte: $28000000 (Series B)
        • Afferent Pharmaceuticals: $5000000 (Series B)
        • Afferent Pharmaceuticals: $23000000 (Series A)
        • Regado Biosciences: $51000000 (Series E)
        • Regado Biosciences: $40000000 (Series D)
        • Regado Biosciences: $23000000 (Series C)
        • Tandem Diabetes Care: $13000000 (Series B)
        • NPS Pharmaceuticals: $5000000 (Seed)
        • ReVision Optics: $32000000 (Series Unknown)
        • ReVision Optics: $55000000 (Series E)
        • ReVision Optics: $15000000 (Series E)
        • ReVision Optics: $35000000 (Series D)
        • ReVision Optics: $25000000 (Series D)
        • Colorescience: $15000000 (Series B)
        • Otonomy: $49000000 (Series D)
        • Otonomy: $46000000 (Series C)
        • Otonomy: $39000000 (Series B)
        • Otonomy: $39000000 (Series B)
        • VIVUS: (Seed)
        • SonoThera: $61000000 (Series A)
        • Immunitas Therapeutics: $58000000 (Series B)
        • Dicerna Pharmaceuticals: $70000000 (Post Ipo Debt)
        • Dicerna Pharmaceuticals: $60000000 (Series C)
        • Bionano Genomics: $32000000 (Series D)
        • Bionano Genomics: $10000000 (Series D)
        • Bionano Genomics: $53000000 (Series C)
        • Bionano Genomics: $10000000 (Series C)
        • Bionano Genomics: $10000000 (Series B)
        • Bionano Genomics: $23000000 (Series B)
        • Kona Medical: $10000000 (Debt Financing)
        • Kona Medical: $10000000 (Series C)
        • Kona Medical: $30000000 (Series C)
        • Carticept Medical: $10000000 (Series C)
        • Carticept Medical: $20000000 (Series B)
        • Carticept Medical: (Series A)
        • Eddingpharm (Cayman): $24000000 (Series B)
        • Corridor Pharmaceuticals: $13000000 (Series A)
        • Alimera Sciences: $5000000 (Series C)
        • Alimera Sciences: $30000000 (Series C)
        • Alimera Sciences: $32000000 (Series B)
        • Alimera Sciences: $27000000 (Series A)
        • Oraya Therapeutics: $42000000 (Series C)
        • Esprit Pharma: $25000000 (Series B)
        • Esprit Pharma: $91000000 (Series B)
        • Esprit Pharma: $100000000 (Series A)
        • Vanda Pharmaceuticals: $19000000 (Series B)
        • Milestone Pharmaceuticals: $80000000 (Series D)
        • Milestone Pharmaceuticals: $55000000 (Series C)
        • Milestone Pharmaceuticals: $17000000 (Series B)
        • Epic Sciences: $24000000 (Series G)
        • Epic Sciences: $52000000 (Series E)
        • Epic Sciences: $40000000 (Series D)
        • Epic Sciences: $30000000 (Series C)
        • Epic Sciences: $13000000 (Series B)
        • ROX Medical: $40000000 (Series E)
        • ROX Medical: $6000000 (Series D)
        • ROX Medical: $33000000 (Series C)
        • ROX Medical: $10000000 (Series B)
        • Sera Prognostics: $20000000 (Series B)
        • Sera Prognostics: $5000000 (Series B)
        • Sera Prognostics: $19000000 (Series A)
        • Evofem Biosciences: $8000000 (Series C)
        • Evofem Biosciences: $21000000 (Series C)
        • Evofem Biosciences: $21000000 (Series C)
        • Ariosa Diagnostics: $53000000 (Series C)
        • BiPar Sciences: $20000000 (Series C)
        • BiPar Sciences: $35000000 (Series B)
        • Sonexa Therapeutics: $30000000 (Series A)
        • Syndax Pharmaceuticals: $80000000 (Series C)
        • Syndax Pharmaceuticals: $27000000 (Series B)
        • Syndax Pharmaceuticals: $27000000 (Series B)
        • Syndax Pharmaceuticals: $9000000 (Series A)
        • Syndax Pharmaceuticals: $40000000 (Series A)
        • RightCare Solutions: $5000000 (Series B)
        • RightCare Solutions: $2000000 (Series A)
        • Kalidex Pharmaceuticals: $7000000 (Series Unknown)
        • Axial Biotherapeutics: $37000000 (Series C)
        • Axial Biotherapeutics: $19000000 (Series A)
        • Axial Biotherapeutics: $20000000 (Series A)
        • Signifier Medical Technologies: $10000000 (Series C)
        • ChromaCode: $28000000 (Series C)
        • ChromaCode: $12000000 (Series B)
        • Gene Sciences, Inc.: $8000000 (Series A)
        • Applied Proteomics: $28000000 (Series C)
        • Applied Proteomics: $23000000 (Series B)
        • aTyr Pharma: $49000000 (Series D)
        • aTyr Pharma: $23000000 (Series C)
        • Ocunexus Therapeutics: $20000000 (Series B)
        • Ocunexus Therapeutics: $19000000 (Series B)
        • Ocunexus Therapeutics: $20000000 (Series A)
        • Astute Medical: $40000000 (Series C)
        • Astute Medical: $13000000 (Series B)
        • Astute Medical: $27000000 (Series B)
        • IntegenX: $40000000 (Series C)
        • IntegenX: $16000000 (Series B)
        • IntegenX: $18000000 (Series B)
        • NeuroPace: $49000000 (Series Unknown)
        • NeuroPace: $30000000 (Series Unknown)
        • ProteinSimple: $33000000 (Series F)
        • ProteinSimple: $10000000 (Series C)
        • ProteinSimple: $27000000 (Series B)
        • Zogenix: $15000000 (Series Unknown)
        • Zogenix: $36000000 (Series B)
        • Zogenix: $18000000 (Series B)
        • Zogenix: $60000000 (Series A)
        • GenVault: $13000000 (Series B)
        • GenVault: $18000000 (Series Unknown)
        • GenVault: $23000000 (Series A)
        • GenVault: $13000000 (Series A)
        • GenVault: $10000000 (Series A)
        • Five Prime Therapeutics: $45000000 (Series Unknown)

        Domain Associates

        New York - Princeton New Jersey, U.S.A.

        Contact this investors  
        Investing In

        Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • CleanTech • HealthTech (& Fitness) • Material Science • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Life Science • Oncology • Pharmaceutical (& Medicine)

        Description

        Domain Associates is a venture capital firm that was founded in 1985 and is based in Princeton, New Jersey. The firm invests in companies operating in therapeutics, medical devices, clinical diagnostics, healthcare and pharmaceutical sectors.

        main investor picture
          Thylacine Capital
          Investing in Businesses Solutions • FinTech ...
           Hoboken New Jersey , ..., U.S.A.
          • main investor picture
            Shay Grinfeld
            Managing Partner
          Investor Picture
          Previous Investments
          • Coralogix: $140000000 (Series D)
          • Coralogix: $55000000 (Series C)
          • Quali: $54000000 (Series D)
          • BigPanda: $23000000 (Series B)

          Thylacine Capital

          Hoboken New Jersey - New York, U.S.A.

          Contact this investors  
          Investing In

          Businesses Solutions • FinTech (& Financials services) • Consumer

          main investor picture
            Colchester Capital, LLC
            Investing in
             New Jersey, United States
            Investor Picture

            Colchester Capital, LLC

            New Jersey, United States

            Contact this investors  
            main investor picture
              New Jersey Economic Development Authority
              Investing in
               New Jersey, United States
              Investor Picture

              New Jersey Economic Development Authority

              New Jersey, United States

              Contact this investors  
              main investor picture
                Cardinal Partners
                Investing in Software (Web Marketplace Saas..) &b...
                 New Jersey, United States
                • main investor picture
                  John Clarke
                  Managing Partner
                • main investor picture
                  Thomas McKinley
                  General Partner
                Investor Picture
                Previous Investments
                • Privia Health: $400000000 (Other)
                • Vividion Therapeutics: $50000000 (Early stage VC)
                • Ivenix: $42000000 (Later stage VC)
                • lifeIMAGE: $17641798 (Later stage VC)
                • Cureatr: $13000000 (Later stage VC)
                • Cardinal Analytx Solutions: $6100000 (Early stage VC)
                • Cardinal Analytx:

                Cardinal Partners

                New Jersey, United States

                Contact this investors  
                Investing In

                Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • CleanTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Life Science

                Description

                Cardinal Partners is a venture capital firm which invests in seed and early stage companies operating in the life sciences, biotechnology and healthcare sectors. The firm was established in 1996 and is based in Princeton, New Jersey.

                main investor picture
                  Rosemark Capital
                  Investing in Software (Web Marketplace Saas..) &b...
                   New Jersey, United States
                  • main investor picture
                    Chris Kuenne
                    Partner, Managing Director
                  Investor Picture

                  Rosemark Capital

                  New Jersey, United States

                  Contact this investors  
                  Investing In

                  Software (Web Marketplace Saas..) • Media • Businesses Solutions • FinTech (& Financials services) • HealthTech (& Fitness)

                  main investor picture
                    Friend Skoler & Co., Inc.
                    Investing in HealthTech (& Fitness) • Logist...
                     New Jersey, United States
                    • main investor picture
                      Steven Skoler
                      Managing Director
                    Investor Picture

                    Friend Skoler & Co., Inc.

                    New Jersey, United States

                    Contact this investors  
                    Investing In

                    HealthTech (& Fitness) • Logistics (& Distribution) • Real Estate (& Construction)

                    Join the community!
                    Connect with investors & startup founders

                    Most active VC firms in New Jersey?

                    Top Angel Investors

                    New Jersey's startup ecosystem benefits from the presence of active angel investors such as David S. Rose and Esther Dyson. These investors are known for their strategic investments in early-stage ventures, particularly in technology and healthcare sectors. Angel investor groups such as Jumpstart NJ Angel Network also play a crucial role in nurturing startups in the region.

                    Leading Venture Capital Firms

                    Prominent venture capital firms operating in New Jersey include Edison Partners and Tech Council Ventures. Edison Partners is renowned for its investments in fintech and healthcare IT, while Tech Council Ventures focuses on a broad range of sectors, including enterprise software and life sciences. These firms provide not only capital but also strategic guidance to their portfolio companies.

                    Investment Size and Scope

                    Investment sizes in New Jersey typically range from $100,000 to several million dollars, depending on the stage and sector of the startup. Angel investors often provide seed funding, while venture capital firms can lead Series A and beyond, offering substantial financial support to scale businesses.

                    Number of Investments

                    In recent years, the number of investments in New Jersey has been on the rise, with dozens of startups receiving funding annually. Both angel investors and venture capital firms are actively involved in numerous deals, contributing to the growth of the local startup ecosystem.

                    Future Outlook of the Investment Market

                    The investment market in New Jersey is expected to continue its upward trajectory, driven by the state's strong educational institutions and proximity to major financial hubs. Sectors such as biotechnology, fintech, and clean energy are anticipated to attract increased investor interest.

                    Support and Mentorship

                    Angel investors and venture capitalists in New Jersey provide more than just financial backing; they offer valuable mentorship and industry connections. This support is crucial for startups navigating the complexities of scaling their operations and entering new markets.

                    Government and Institutional Support

                    New Jersey's government and institutions such as the New Jersey Economic Development Authority (NJEDA) offer various programs and incentives to support startups. These initiatives aim to foster innovation and attract both domestic and international investments to the state.

                    Conclusion

                    New Jersey presents a fertile ground for startups, with a robust network of angel investors and venture capital firms. The state's supportive environment and strategic location make it an attractive destination for entrepreneurs seeking investment and growth opportunities.

                    Comprehensive Guides to Raising Funds Online

                    By clicking on "Create Account" you accept our terms of service

                    Already have an account?
                    Login
                    Mike testimonial

                    Michael Colin - Founder of The MVMT



                    "We met the perfect Angel Investor within the Angels Partners Investors' Community. We received a $250,000 check after 2 months of discussions with investors on the platform."

                    Taylor Testimonial

                    Taylor Matter - Founder & CEO, Hurdle Apparel



                    "Raising Capital for a consumer venture can be rather difficult and Angels Partners helped connect the dots and helped us meet 2 investors who investors $200,000 in our brand."

                    founder clement

                    Clément Perrot - Co-Founder & CEO of Prynt



                    "Met really good investors who invested in Prynt, that I wouldn’t have met otherwise. Angels Partners helped us close our round quicker and with the right people."


                    Create An Account
                    Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
                    proof notifcation
                    32 New StartupsStarted their fundraisingover the last 7 days